OKUMA

This brand name is authorized in Nigeria.

Active ingredients

The drug OKUMA contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 6TGQ35Z71K - DICLOFENAC DIETHYLAMINE
 

Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms.
 
Read more about Diclofenac
2
UNII LAV5U5022Y - METHYL SALICYLATE
 

Methyl salicylate has the action of salicylates, causing dilation of the skin vessels. Methyl salicylate is used to prevent bed sores and for hardening the skin of the feet.
 
Read more about Methyl salicylate
3
UNII L7T10EIP3A - MENTHOL, UNSPECIFIED FORM
 
Read more about Menthol
4
Linseed oil
UNII 84XB4DV00W - LINSEED OIL

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
B4-3716 Cream OKUMA CREAM CREAM 1.16%; 3.00%; 10.00%; 5.00% 1X30G OKUMA CREAM DICLOFENAC DIETHYLAMMONIUM, ETC DICLOFENAC DIETHYLAMINE BP 1.16%W/W, EQ. TO DICLOFENAC SODIUM BP 1.1% W/W, LINSEED OIL BP 3.00% W/W, METHYL SALICYLATE BP 10.00%W/W, MENTHOL BP 5.00%W/W, CREAM BASE QS B4-3716 Drugs Imported Products 1X30G Prescription Only Medicine (POM) 11/11/2022 ELBE PHARMA NIGERIA LIMITED, 1, AFRICAN CHURCH CLOSE, OFF COKER ROAD, ILUPEJU, LAGOS STATE, NIGERIA. 8069718539 elbepharma.rgn@gmail.com LESANTO LABORATORIES, PLOT NO. 9, 10, 11 & 20, SURVEY NO 53, NEAR RAILWAY BRIDGE, THANE PALGHAR 401404 MAHARASHTRA, INDIA, India 26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
M02AA Antiinflammatory preparations, non-steroids for topical use M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain
Discover more medicines within M02AA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database B4-3716

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈